| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $287.0M | -49.7% |
| Cost of Revenue | $228.0M | -43.7% |
| Gross Profit | $59.0M | -64.5% |
| R&D Expense | $152.0M | -21.6% |
| SG&A Expense | $92.0M | -20.7% |
| Operating Income | -$328.0M | +17.6% |
| Pre-tax Income | -$312.0M | +18.5% |
| Income Tax | $5.0M | +400.0% |
| Net Income | -$317.0M | +17.4% |
| EPS (Basic) | -$13.36 | -2243.9% |
| EPS (Diluted) | -$13.36 | -2243.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $238.0M | -53.0% |
| Short-term Investments | $144.0M | -32.4% |
| Current Assets | $410.0M | -47.2% |
| Total Assets | $423.0M | -47.1% |
| Current Liabilities | $196.0M | -36.6% |
| Total Liabilities | $206.0M | -36.0% |
| Stockholders' Equity | $217.0M | -54.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$341.0M | +19.2% |
| Capital Expenditures | $3.0M | +50.0% |
| Investing Cash Flow | $74.0M | +257.4% |
| Financing Cash Flow | -$5.0M | +77.3% |
| Free Cash Flow | -$344.0M | +18.9% |